Marino Garcia, CEO and President of Dianthus Therapeutics, Inc., executed a significant sale of company shares on March 12, 2026. Garcia sold 65,517 shares at an average price of $81.74 per share, resulting in a total transaction value of approximately $5.36 million.
This transaction follows other recent insider selling activity within Dianthus Therapeutics. On the same day, Garcia also sold smaller tranches of shares, and Simrat Randhawa, another insider, sold 33,830 shares for roughly $2.76 million.
Insider sales can be influenced by various personal financial decisions, such as portfolio diversification or tax planning, and do not necessarily indicate a change in the company's fundamental outlook.